CD44:癌症干细胞标记物和白血病治疗中的治疗点
Shuang Wu1,2, Yicheng Tan1,2,3, Fanfan Li2,3,4
1Laboratory Animal Center, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
CD44是一种细胞粘附分子,通过调解白血病干细胞与环境之间的相互作用,在白血病发展中发挥关键作用. 研究探讨CD44变体作为白血病干预的生物标志物和治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- CD44是一种无处不在的白细胞粘附分子,对细胞相互作用,迁移和分化至关重要.
- 它调解白血病干细胞 (LSC) 和细胞外基质 (ECM) 之间的相互作用,影响调节LSC行为的信号通路.
- 异常的CD44表达与包括白血病在内的各种癌症有关.
研究的目的:
- 审查CD44标准 (CD44s) 和变异性 (CD44v) 异构体作为白血病发展中的生物标志物的作用.
- 讨论关于白血病中CD44相关信号通路的当前研究.
- 探索临床白血病治疗中针对CD44的干预措施的前景.
主要方法:
- 文献综述专注于研究研究CD44表达和功能在白血病.
- 对CD44作为白血病诊断和预后的生物标志物的研究分析.
- 检查评估针对CD44的治疗方法的临床前和临床研究.
主要成果:
- CD44异型 (CD44s和CD44v) 与白血病干细胞种群和疾病进展有显著的关联.
- CD44介导的信号通路对LSC的生存,自我更新和对治疗的抵抗至关重要.
- 特定的CD44变异可能成为白血病患者风险分层和治疗选择的有价值生物标志物.
结论:
- CD44异型代表了理解白血病发育和进展的有希望的生物标志物.
- 向CD44介导通路提供了一种潜在的治疗策略,以克服白血病的治疗耐药性.
- 需要进一步的研究,以充分阐明基于CD44的白血病诊断和治疗的临床实用性.
更多相关视频
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
07:03Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples
Published on: October 2, 2020
相关概念视频
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Regulation of Hematopoietic Stem Cells
Differentiation of Common Myeloid Progenitor Cells
